Quantcast

Bay State News

Tuesday, April 22, 2025

FDA conducted lowest number of inspections on Drugs companies in Massachusetts during Q1

Webp ishuwpt6uyanzpnvvfpnzrwi0yoq

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website

In the first quarter of 2025, two Drugs companies received two FDA inspections in Massachusetts, according to the U.S. Food and Drug Administration (FDA).

This was the lowest number of inspections per type of company made by the FDA in Massachusetts, equalling 7.4% of all inspections in the first quarter of 2025.

Of all the Massachusetts companies involved in the Drugs sector, Alnylam Pharmaceuticals, Inc. received the most citations from the FDA in the first quarter of 2025.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.

FDA Inspections in Massachusetts During Q1
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products1
Compliance: Devices11
Drug Quality Assurance2
Food Composition, Standards, Labeling and Econ41
Foodborne Biological Hazards155
Human Cellular, Tissue, and Gene Therapies2
Postmarket Assurance: Devices11
Technical Assistance: Food and Cosmetics1

MORE NEWS